NASDAQ Rheumatology Market News

Anthera Pharmaceuticals Announces Completion of Dosing in CHABLIS-SC1 Phase 3 Clinical Study with Blisibimod

HAYWARD, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announced that ...

Apricus Biosciences to Present at the Canaccord Genuity 36th Annual Growth Conference

SAN DIEGO, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

Horizon Pharma plc to Host Second-Quarter 2016 Conference Call and Webcast on August 8, 2016

DUBLIN, Ireland, July 07, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical ...

Apricus Biosciences Enters Into Common Stock Purchase Agreement With Aspire Capital

SAN DIEGO, July 06, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI) (the “Company” ...

Rheumatology Leaders Respond to MACRA Proposed Rule

WASHINGTON, June 24, 2016 (GLOBE NEWSWIRE) -- In comments submitted to the Centers for ...